Events

  • 13/09/2021

    H.C. Wainwright 23rd Annual Global Investment Conference

  • 09/09/2021

    Morgan Stanley 19th Annual Global Healthcare Conference

  • 08/09/2021

    Company’s semi-annual report for I half of 2021

  • 10/08/2021

    12th Annual Wedbush PacGrow Healthcare Conference

  • 22/06/2021

    GPW Innovation

  • 11/06/2021

    Discussion On Ryvu Data Presented at EHA 2021 – Conference Call

  • 09/06/2021

    EHA2021 Virtual Congress

  • 09/06/2021

    Synthetic lethality in cancer treatment – Ryvu Therapeutics seminar

  • 04/06/2021

    ASCO Annual Meeting 2021

  • 26/05/2021

    STING & TLR-Targeting Therapies Digital Summit

  • 26/05/2021

    Erste Group Innovation Conference 2021

  • 25/05/2021

    UBS Global Healthcare Virtual Conference

  • 12/05/2021

    Company’s quarterly report for I quarter of 2021

  • 16/03/2021

    Publication of the annual report for 2020

  • 19/11/2020

    Publication of Q3 2020 financial report

  • 15/09/2020

    Publication of H1 2020 financial report

  • 14/09/2020

    virtual

    H.C Wainwright & Co. – 22nd Annual Global Investment Conference

  • 10/06/2020

    Publication of Q1 2020 financial report

  • 16/04/2020

    live.ryvu.com

    Annual Financial Results 2019 video conference: Main Achievements in 2019 and Outlook for 2020 – 11.00 AM (CET) –

  • 09/04/2020

    Publication of Annual Report for 2019

  • 02/04/2020

    Solebury Trout Virtual Investor Conference

  • 23/03/2020

    Paris, France

    BIO Europe Spring 2020

  • 07/12/2019

    Orlando, FL, USA

    Ryvu Therapeutics at the 61st ASH Annual Meeting & Exposition

  • 07/12/2019

    Orlando, FL, USA

    61st ASH Annual Meeting & Exposition

  • 20/11/2019

    London, UK

    Jefferies London Healthcare Conference

  • 11/11/2019

    Hamburg, Germany

    Ryvu Therapeutics presents at BIO-Europe 2019

  • 06/11/2019

    Consolidated quarterly Q3 2019 report publication

  • 06/11/2019

    National Harbor MD, USA

    34th Annual Meeting & Pre-Conference Programs (SITC 2019)

  • 10/11/2021

    Company’s quarterly report for III quarter of 2021

Presentations

Ryvu Therapeutics

Corporate presentation: September 2021

PDF